Interferon-lambda and therapy for chronic hepatitis C virus infection

被引:72
作者
Donnelly, Raymond P. [1 ]
Dickensheets, Harold [1 ]
O'Brien, Thomas R. [2 ]
机构
[1] US FDA, Div Therapeut Prot, Ctr Drug Evaluat & Res, Bethesda, MD 20892 USA
[2] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
REGULATORY FACTOR FAMILY; IFN-LAMBDA; GENETIC-VARIATION; DENDRITIC CELLS; DIFFERENTIAL EXPRESSION; ANTIVIRAL RESPONSES; VIRAL-INFECTION; INTERLEUKIN; 28B; III IFN; NON-A;
D O I
10.1016/j.it.2011.07.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Interferon (IFN)-alpha, a type-I IFN, is widely used to treat chronic hepatitis C virus infection, but the broad expression of IFN-alpha receptors often leads to adverse reactions in many organs. Here, we examine IFN-lambda, a type-III IFN, as a therapeutic alternative to IFN-alpha. Like IFN-alpha, IFN-lambda also induces antiviral activity in hepatocytes, but might induce fewer adverse reactions because its receptor is largely restricted to cells of epithelial origin. We also discuss the recent discovery of single nucleotide polymorphisms (SNPs) near the human IFN-lambda 3 gene, IL28B, that correlate strongly with the ability to achieve a sustained virological response to therapy with pegylated IFN-alpha plus ribavirin in patients with chronic hepatitis C.
引用
收藏
页码:443 / 450
页数:8
相关论文
共 64 条
[1]
Pegylated interferons α2a and α2b in the treatment of chronic hepatitis C [J].
Aghemo, Alessio ;
Rumi, Maria Grazia ;
Colombo, Massimo .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2010, 7 (09) :485-494
[2]
Amino Acid Substitution in Hepatitis C Virus Core Region and Genetic Variation Near the Interleukin 28B Gene Predict Viral Response to Telaprevir with Peginterferon and Ribavirin [J].
Akuta, Norio ;
Suzuki, Fumitaka ;
Hirakawa, Miharu ;
Kawamura, Yusuke ;
Yatsuji, Hiromi ;
Sezaki, Hitomi ;
Suzuki, Yoshiyuki ;
Hosaka, Tetsuya ;
Kobayashi, Masahiro ;
Kobayashi, Mariko ;
Saitoh, Satoshi ;
Arase, Yasuji ;
Ikeda, Kenji ;
Chayama, Kazuaki ;
Nakamura, Yusuke ;
Kumada, Hiromitsu .
HEPATOLOGY, 2010, 52 (02) :421-429
[3]
Lambda interferon (IFN-λ), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo [J].
Ank, N ;
West, H ;
Bartholdy, C ;
Eriksson, K ;
Thomsen, AR ;
Paludan, SR .
JOURNAL OF VIROLOGY, 2006, 80 (09) :4501-4509
[5]
Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection [J].
Chen, LM ;
Borozan, I ;
Feld, J ;
Sun, J ;
Tannis, LL ;
Coltescu, C ;
Heathcote, J ;
Edwards, AM ;
McGilvray, ID .
GASTROENTEROLOGY, 2005, 128 (05) :1437-1444
[6]
ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME [J].
CHOO, QL ;
KUO, G ;
WEINER, AJ ;
OVERBY, LR ;
BRADLEY, DW ;
HOUGHTON, M .
SCIENCE, 1989, 244 (4902) :359-362
[7]
Viral infection and Toll-like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte-derived dendritic cells [J].
Coccia, EM ;
Severa, M ;
Giacomini, E ;
Monneron, D ;
Remoli, ME ;
Julkunen, I ;
Cella, M ;
Lande, R ;
Uzé, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (03) :796-805
[8]
Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1 [J].
Conjeevaram, Hari S. ;
Fried, Michael W. ;
Jeffers, Lennox J. ;
Terrault, Norah A. ;
Wiley-Lucas, Thelma E. ;
Afdhal, Nezam ;
Brown, Robert S. ;
Belle, Steven H. ;
Hoofnagle, Jay H. ;
Kleiner, David E. ;
Howell, Charles D. .
GASTROENTEROLOGY, 2006, 131 (02) :470-477
[9]
Regulation of IFN regulatory factor-7 and IFN-α production by enveloped virus and lipopolysaccharide in human plasmacytoid dendritic cells [J].
Dai, JH ;
Megjugorac, NJ ;
Amrute, SB ;
Fitzgerald-Bocarsly, P .
JOURNAL OF IMMUNOLOGY, 2004, 173 (03) :1535-1548
[10]
Type I interferon receptors: Biochemistry and biological functions [J].
de Weerd, Nicole A. ;
Samarajiwa, Shamith A. ;
Hertzog, Paul J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (28) :20053-20057